Announced details
Central nervous system, neuroscience, regenerative medicine, developmental biology, neurosurgery, quantum life sciences, ophthalmology
Joint research relationship. No capital or personnel relationship is stated.
The Keio University Regenerative Medicine Research Center is a research center headed by Professor Hideyuki Okano (岡野栄之) as director. The RIKEN Center for Brain Science is a research center where Professor Hideyuki Okano (岡野栄之) serves as team director.
Keio University Tonomachi Town Campus
The company states that the center will accelerate the creation and advancement of the pipeline, but no specific impact on earnings has been disclosed.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Joint research and research center relating to the non-visual receptor OPN5 |
| Counterparty | Keio University Regenerative Medicine Research Center, RIKEN Center for Brain Science |
| Counterparty overview | The Keio University Regenerative Medicine Research Center is a research center headed by Professor Hideyuki Okano (岡野栄之) as director. The RIKEN Center for Brain Science is a research center where Professor Hideyuki Okano (岡野栄之) serves as team director. |
| Relationship with the Company | Joint research relationship. No capital or personnel relationship is stated. |
| Launch date | 24 June 2026 (already opened) |
| Applicable area | Central nervous system, neuroscience, regenerative medicine, developmental biology, neurosurgery, quantum life sciences, ophthalmology |
| Location | Keio University Tonomachi Town Campus |
| Location scale | Approximately 7 people, including professors, with approximately 5 PI and research staff. Dedicated laboratories, cell culture facilities, and an environment for light-stimulation experiments have been established. |
| Impact on Business Performance | The company states that the center will accelerate the creation and advancement of the pipeline, but no specific impact on earnings has been disclosed. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To elucidate the functions of OPN5 in the central nervous system and the molecular characteristics and physiological functions of human OPN5, thereby accelerating the creation of new research seeds and the creation and advancement of the pipeline.